Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q2 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Ovid Therapeutics Inc. (OVID) click here.